afamitresgene autoleucel (Tecelra)
Jump to navigation
Jump to search
Indications
- metastatic synovial sarcoma (FDA-approved)
Dosage
250 mL afamitresgene autoleucel 40000000 cells/mL Injection
More general terms
References
- ↑ Winstead E FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma National Cancer Institure. Aug 27, 2025 https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-tecelra-synovial-sarcoma-mage-a4